Favoriten Anmelden
  1. Home
  2. Alle Unternehmen
  3. Assembly Biosciences
  4. Finanzdaten
  5. Gewinn / Verlust
  6. Anteile
Assembly Biosciences logo
Assembly Biosciences ASMB
€ 20.31 0.89%
report update icon

Quartalsbericht 2026-Q2
hinzugefügt 13.08.2026

Assembly Biosciences Anteile | ASMB

Anteile Jährlich Assembly Biosciences

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2005
11.2 M 6 M 4.58 M 4.03 M 43.3 M 35.5 M 26.3 M 22.8 M 17.8 M 17.2 M 15.7 M 7 M 3.88 M 2.55 M 1.92 M 620 K - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
43.3 M 620 K 13.8 M

Anteile Vierteljährlich Assembly Biosciences

2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
7.66 M 16.9 M - 12.7 M 7.66 M 7.51 M 7.46 M 6.35 M 5.64 M 5.48 M 5.48 M 4.38 M 4.36 M 4.25 M 48.9 M 48.4 M 48.3 M 48.1 M 48.1 M 45.6 M 42.9 M 39.7 M 34 M 35.5 M 35.3 M 35.1 M 32.6 M 25.9 M 25.7 M 25.7 M 25.5 M 24.9 M 20.5 M 20.2 M 20.1 M 17.4 M 17.3 M 17.3 M 17.2 M 17.2 M 17.2 M 17.2 M 17.2 M 17.2 M 17.1 M 11.2 M 10.7 M 8.28 M 4.7 M 4.42 M 4.15 M 3.98 M 3.94 M 17.1 M 12.9 M 12.9 M 12.6 M 12.4 M 12.4 M 11.6 M 7.18 M 12.4 M

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
48.9 M 3.94 M 19.1 M

Anteile anderer Aktien in der Pharmaeinzelhändler

Name Anteile Preis % 24h Marktkapitalisierung Land
IVERIC bio IVERIC bio
ISEE
 		121 M - - $ 5.51 B usaUSA
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
 		93 M - -0.04 % $ 2.62 B usaUSA
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
 		4.25 M - -45.12 % $ 2.85 M usaUSA
Metacrine Metacrine
MTCR
 		27.2 M - - $ 24.2 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
 		38.8 M - - $ 10.1 M usaUSA
Molecular Templates Molecular Templates
MTEM
 		4.5 M - -23.43 % $ 495 K usaUSA
CohBar CohBar
CWBR
 		2.9 M - -15.44 % $ 2.2 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		85.1 M - - $ 2.18 B usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
 		43.3 M - - $ 105 M usaUSA
Global Blood Therapeutics Global Blood Therapeutics
GBT
 		63 M - - $ 4.62 B usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
 		3.26 M - -23.04 % $ 26.6 M usaUSA
ImmunoGen ImmunoGen
IMGN
 		254 M - - $ 7.92 B usaUSA
Infinity Pharmaceuticals Infinity Pharmaceuticals
INFI
 		89.2 M - -46.98 % $ 3.57 M usaUSA
Novan Novan
NOVN
 		22 M - -24.84 % $ 2.64 M usaUSA
NanoString Technologies NanoString Technologies
NSTG
 		46.4 M - -37.43 % $ 5.1 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		99.3 M - -4.8 % $ 255 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
 		15.8 M - 2.71 % $ 14 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		45 M - - $ 26.5 M usaUSA
Aptinyx Aptinyx
APTX
 		67.7 M - -39.0 % $ 4.57 M usaUSA
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
 		34.4 M - - $ 521 M usaUSA
Inozyme Pharma Inozyme Pharma
INZY
 		62.8 M - - $ 207 M usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
 		419 M - -29.58 % $ 126 M usaUSA
Surface Oncology Surface Oncology
SURF
 		55.8 M - - $ 59.7 M usaUSA
Orgenesis Orgenesis
ORGS
 		4.21 M - -33.86 % $ 61.2 M usaUSA
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
 		64.7 M $ 12.97 0.78 % $ 839 M usaUSA
Inhibrx Inhibrx
INBX
 		47.1 M $ 94.56 0.92 % $ 4.46 B usaUSA
RedHill Biopharma Ltd. RedHill Biopharma Ltd.
RDHL
 		12.3 B $ 0.49 1.0 % $ 6.04 B israelIsrael
Tiziana Life Sciences PLC Tiziana Life Sciences PLC
TLSA
 		107 M $ 1.07 0.45 % $ 114 M britainBritain
XTL Biopharmaceuticals Ltd. XTL Biopharmaceuticals Ltd.
XTLB
 		673 M $ 2.18 0.93 % $ 1.47 B israelIsrael
Zymeworks Zymeworks
ZYME
 		51.6 M $ 26.21 4.21 % $ 1.35 B canadaCanada
Adverum Biotechnologies Adverum Biotechnologies
ADVM
 		19.8 M - - $ 86.2 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
 		67.1 M - - $ 3.67 B usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
 		6.35 M - - $ 1.41 B usaUSA
Corner Growth Acquisition Corp. Corner Growth Acquisition Corp.
COOL
 		9.83 M - -0.89 % $ 114 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
 		130 M - - $ 2.02 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
 		19.7 M - - $ 591 K irlandaIrlanda
Mersana Therapeutics Mersana Therapeutics
MRSN
 		123 M - - $ 3.56 B usaUSA
Humanigen Humanigen
HGEN
 		89.2 M - -81.12 % $ 4.28 M usaUSA
Morphic Holding Morphic Holding
MORF
 		42.4 M - - $ 2.42 B usaUSA
Jounce Therapeutics Jounce Therapeutics
JNCE
 		51.7 M - - $ 98.4 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		15.4 M - - $ 7.46 M israelIsrael
Verona Pharma plc Verona Pharma plc
VRNA
 		652 M - - $ 69.7 B britainBritain
Clovis Oncology Clovis Oncology
CLVS
 		128 M - -7.23 % $ 13 M usaUSA
Allakos Allakos
ALLK
 		88.8 M - - $ 28.6 M usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
 		34.4 M - - $ 401 M usaUSA
Evelo Biosciences Evelo Biosciences
EVLO
 		87.2 M - -14.46 % $ 27.9 M usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
 		59.3 M - - $ 384 M britainBritain
Genocea Biosciences Genocea Biosciences
GNCA
 		68.6 M - -15.0 % $ 3.04 M usaUSA
Amryt Pharma plc Amryt Pharma plc
AMYT
 		236 M - - $ 621 M britainBritain
G1 Therapeutics G1 Therapeutics
GTHX
 		51.7 M - - $ 370 M usaUSA